Hyclone Life Sciences Solutions India Private Limited, a active private limited company, was established on 01 August 2019 in Bangalore, Karnataka, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U24304KA2019PTC126720. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹245.00 Cr and a paid-up capital of ₹235.16 Cr.
Employing 496 professional, Its leadership includes Satya Prasad Udandravu (Director), Ramakrishna Panicker Manoj Kumar (Director), Balasubramanian Narayanan Iyer (Additional Director). Past directors included Satya Prasad Udandravu, Raghavendra Goud Vaggu, Ganesh Karnatakam. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Galileo, John F Welch Technology Centre, 122 Epip Zone Phase Ii, Hoodi Village, White, Field Road, Bangalore, Karnataka, 560066.
U24304KA2019PTC126720
126720
01 August 2019
₹245.00 Cr
₹235.16 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Hyclone Life Sciences Solutions India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satya Prasad Udandravu | Director | 14 Jun 2022 | Current |
| Ramakrishna Panicker Manoj Kumar | Director | 05 Jun 2024 | Current |
| Balasubramanian Narayanan Iyer | Additional Director | 12 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 30 Aug 2022 | Past |
| Pramod Abcsdd | Director | 14 Jun 2022 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 31 Mar 2020 | Past |
| Pramod Abcsdd | Director | 31 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hyclone Life Sciences Solutions India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.7% increase. The company also saw a substantial fall in profitability, with a 20.38% decrease in profit. The company's net worth Soared by an impressive increase of 38.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Hyclone Life Sciences Solutions India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Hyclone Life Sciences Solutions India has a workforce of 496 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hyclone Life Sciences Solutions India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyclone Life Sciences Solutions India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Hyclone Life Sciences Solutions India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Hyclone Life Sciences Solutions India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
Progress on Balasubramanian Narayanan Iyer was appointed as a Additional Director was appointed as a Additional Director on 12 Mar 2025 & has been associated with this company since 8 months 18 days . was documented.
The activity Ramakrishna Panicker Manoj Kumar was appointed as a Director was appointed as a Director on 05 Jun 2024 & has been associated with this company since 1 year 5 months . was completed.
Satya Prasad Udandravu was appointed as a Director was appointed as a Director on 14 Jun 2022 & has been associated with this company since 3 years 5 months . was recorded as a recent event.
The activity Amol Laxman Kulkarni was appointed as a Company Secretary was appointed as a Company Secretary on 06 Mar 2020 & has been associated with this company since 5 years 8 months . was completed.
The CIN of Hyclone Life Sciences Solutions India Private Limited is U24304KA2019PTC126720.
Hyclone Life Sciences Solutions India Private Limited is headquartered at Galileo, John F Welch Technology Centre, 122 Epip Zone Phase Ii, Hoodi Village, White, Field Road, Bangalore, Karnataka, 560066.
Hyclone Life Sciences Solutions India Private Limited was incorporated on 01 August 2019.
The current directors of Hyclone Life Sciences Solutions India Private Limited are
The primary industry of Hyclone Life Sciences Solutions India Private Limited is Professional, Scientific And Technical.
Hyclone Life Sciences Solutions India Private Limited is unlisted.
The authorized capital of Hyclone Life Sciences Solutions India Private Limited is ₹245.00 Cr, and the paid-up capital is ₹235.16 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX